These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15633290)

  • 1. The messenger and the message: gp96 (GRP94)-peptide interactions in cellular immunity.
    Nicchitta CV; Carrick DM; Baker-Lepain JC
    Cell Stress Chaperones; 2004; 9(4):325-31. PubMed ID: 15633290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94.
    Nieland TJ; Tan MC; Monne-van Muijen M; Koning F; Kruisbeek AM; van Bleek GM
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6135-9. PubMed ID: 8650232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-regulated protein 94/glycoprotein 96 elicits bystander activation of CD4+ T cell Th1 cytokine production in vivo.
    Baker-LePain JC; Sarzotti M; Nicchitta CV
    J Immunol; 2004 Apr; 172(7):4195-203. PubMed ID: 15034032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical analysis of the endoplasmic reticulum-resident chaperone/heat shock protein gp96/GRP94 and its complex with peptide antigen.
    Linderoth NA; Simon MN; Rodionova NA; Cadene M; Laws WR; Chait BT; Sastry S
    Biochemistry; 2001 Feb; 40(5):1483-95. PubMed ID: 11170476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
    Fleischer K; Schmidt B; Kastenmüller W; Busch DH; Drexler I; Sutter G; Heike M; Peschel C; Bernhard H
    J Immunol; 2004 Jan; 172(1):162-9. PubMed ID: 14688322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer of GRP94(Gp96)-associated peptides onto endosomal MHC class I molecules.
    Berwin B; Rosser MF; Brinker KG; Nicchitta CV
    Traffic; 2002 May; 3(5):358-66. PubMed ID: 11967129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To find the road traveled to tumor immunity: the trafficking itineraries of molecular chaperones in antigen-presenting cells.
    Berwin B; Nicchitta CV
    Traffic; 2001 Oct; 2(10):690-7. PubMed ID: 11576445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical, cell biological and immunological issues surrounding the endoplasmic reticulum chaperone GRP94/gp96.
    Nicchitta CV
    Curr Opin Immunol; 1998 Feb; 10(1):103-9. PubMed ID: 9523119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of processed, H-2Kb-binding ovalbumin-derived peptides associated with the stress proteins HSP70 and gp96.
    Breloer M; Marti T; Fleischer B; von Bonin A
    Eur J Immunol; 1998 Mar; 28(3):1016-21. PubMed ID: 9541597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides.
    Nair S; Wearsch PA; Mitchell DA; Wassenberg JJ; Gilboa E; Nicchitta CV
    J Immunol; 1999 Jun; 162(11):6426-32. PubMed ID: 10352256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of peptide loading by the tumor rejection antigen/heat shock chaperone gp96 (GRP94).
    Sastry S; Linderoth N
    J Biol Chem; 1999 Apr; 274(17):12023-35. PubMed ID: 10207025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity.
    Blachere NE; Li Z; Chandawarkar RY; Suto R; Jaikaria NS; Basu S; Udono H; Srivastava PK
    J Exp Med; 1997 Oct; 186(8):1315-22. PubMed ID: 9334371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.
    Singh-Jasuja H; Toes RE; Spee P; Münz C; Hilf N; Schoenberger SP; Ricciardi-Castagnoli P; Neefjes J; Rammensee HG; Arnold-Schild D; Schild H
    J Exp Med; 2000 Jun; 191(11):1965-74. PubMed ID: 10839811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock protein-peptide complexes for use in vaccines.
    Heike M; Noll B; Meyer zum Büschenfelde KH
    J Leukoc Biol; 1996 Aug; 60(2):153-8. PubMed ID: 8773575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.
    Oizumi S; Strbo N; Pahwa S; Deyev V; Podack ER
    J Immunol; 2007 Aug; 179(4):2310-7. PubMed ID: 17675492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation.
    Li Z; Srivastava PK
    EMBO J; 1993 Aug; 12(8):3143-51. PubMed ID: 8344253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70.
    Robert J; Ménoret A; Basu S; Cohen N; Srivastava PR
    Eur J Immunol; 2001 Jan; 31(1):186-95. PubMed ID: 11265634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural transitions accompanying the activation of peptide binding to the endoplasmic reticulum Hsp90 chaperone GRP94.
    Wearsch PA; Voglino L; Nicchitta CV
    Biochemistry; 1998 Apr; 37(16):5709-19. PubMed ID: 9548957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrated view of the roles and mechanisms of heat shock protein gp96-peptide complex in eliciting immune response.
    Li Z; Dai J; Zheng H; Liu B; Caudill M
    Front Biosci; 2002 Mar; 7():d731-51. PubMed ID: 11861214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress protein/peptide complexes derived from autologous tumor tissue as tumor vaccines.
    Heike M; Weinmann A; Bethke K; Galle PR
    Biochem Pharmacol; 1999 Nov; 58(9):1381-7. PubMed ID: 10513981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.